BDBM269505 (4-(2-fluoro-2-(4- fluorophenyl)ethyl)piperazin-1- yl)(imidazo[1,2-a]pyridin-8- yl)methanone.::US10058549, 10

SMILES FC(CN1CCN(CC1)C(=O)c1cccn2ccnc12)c1ccc(F)cc1

InChI Key InChIKey=RFQBISKRBWMSHN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 269505   

Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Arena Pharmaceuticals Inc

US Patent
LigandPNGBDBM269505((4-(2-fluoro-2-(4- fluorophenyl)ethyl)piperazin-1-...)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Radioligand binding assays for human 5-HT2A serotonin receptor were conducted using the 5-HT2 agonist [125I]DOI as radioligand. To define nonspecific...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Arena Pharmaceuticals Inc

US Patent
LigandPNGBDBM269505((4-(2-fluoro-2-(4- fluorophenyl)ethyl)piperazin-1-...)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Radioligand binding assays for human 5-HT2A serotonin receptor were conducted using the 5-HT2 agonist [125I]DOI as radioligand. To define nonspecific...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent